Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROCHLOROTHIAZIDE Cause Seizure? 124 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Seizure have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 0.6% of all adverse event reports for HYDROCHLOROTHIAZIDE.

124
Reports of Seizure with HYDROCHLOROTHIAZIDE
0.6%
of all HYDROCHLOROTHIAZIDE reports
3
Deaths
97
Hospitalizations

How Dangerous Is Seizure From HYDROCHLOROTHIAZIDE?

Of the 124 reports, 3 (2.4%) resulted in death, 97 (78.2%) required hospitalization, and 6 (4.8%) were considered life-threatening.

Is Seizure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 124 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?

Hyponatraemia (2,138) Drug ineffective (1,889) Acute kidney injury (1,838) Nausea (1,536) Dyspnoea (1,521) Dizziness (1,469) Headache (1,419) Hypotension (1,347) Fall (1,323) Malaise (1,312)

What Other Drugs Cause Seizure?

LEVETIRACETAM (9,961) CANNABIDIOL (4,980) LACOSAMIDE (4,585) LAMOTRIGINE (3,459) ADALIMUMAB (2,510) BRIVARACETAM (2,411) VIGABATRIN (2,289) CARBAMAZEPINE (2,262) PHENYTOIN (1,907) BUPROPION (1,894)

Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Seizure Risk?

HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Related Pages

HYDROCHLOROTHIAZIDE Full Profile All Seizure Reports All Drugs Causing Seizure HYDROCHLOROTHIAZIDE Demographics